Latest news with #SwedishMatch
Yahoo
16-06-2025
- Business
- Yahoo
Philip Morris stock gets a bump from smoke-free Zyn
Philip Morris (PM) shares continue to trade near record highs. The stock has gotten a big boost thanks to its product Zyn, a smoke-free nicotine pouch. Yahoo Finance Senior Reporter Brooke DiPalma takes a closer look at the stock in the video above. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. Well, Philip Morris' stock getting a good buzz from its smoke-free nicotine product Zyn. That stock hitting a record close on Friday. For more, we'll bring in Yahoo Finance senior reporter, Brooke DiPalma. Brooke? Good afternoon, Josh. Certainly record highs stock price for Philip Morris International. On Friday, it hit more than $184 per share. What's really driving that is that Zyn product. Really, its smoke-free portfolio. One analyst telling me that this is part of a multi-year growth story with lots of potential around that smoke-free business. Ever since it acquired Swedish Match a few years ago, that was the owner behind Zyn. And what we've seen here is this demand just keep growing. From Q1 of last year to Q1 of this year, we saw shipments to the US of Zyn cans move from 100 million to more than 200 million. They're passing that 200 million mark. And even since April of 2024, what we actually have seen is this shortage of Zyn here in the US that they say will recover by the third quarter. Now, one thing we also really like here is that it is a high margin business. Each can is only about six grams. So, it doesn't cost a lot to make, doesn't cost a lot to ship here. And also, this category of smoke-free products is really contributing to Philip Morris uh, International's revenue here. We know that as of Q1, which was in April, that business growing about 15% as far as revenue goes, 3.9 billion part of that overall picture of last quarter's revenue of 9.3 billion. Lots to watch there. I told you how, uh, on my commute home to New Jersey every night on that train, Brooke DiPalma, I see those Zyn fans. They're out there. You have been talking also to convenience store CEOs who've been talking about this product and how it's been impacting their business. Yeah, let's be real clear here. I got this story idea after I talked to Casey's General Stores CEO last week. He said specifically the business is growing a lot and some of that is what our merchants have done to give it more, uh, exposure and to reset it. They said, we've helped accelerate that. What he said was that in the last two years, they've seen this nicotine pouch smoke-free business grow 200%. In the last year alone, up 54%. I found that pretty surprising. So, I decided to dive into it. That's incredible. Great reporting. Thank you, Brooke. Appreciate it. Thanks. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
CBS News
09-05-2025
- Business
- CBS News
Baltimore accuses Zyn nicotine pouch owners of targeting children with deceptive marketing
Baltimore is accusing the owners of Zyn nicotine pouches of targeting children with deceptive marketing practices, violating the city's Consumer Protection Ordinance. The lawsuit names the owners of the brand – Philip Morris International, Inc. (PMI), Swedish Match North America LLC and Swedish Match USA, Inc. According to the lawsuit, the companies have targeted children and teens through the marketing of Zyn flavors, exploitative social media promotions and false advertising. "Zyn's manufacturers have put profits ahead of the health and safety of Baltimoreans, in particular our children, through manipulative marketing practices, and my office won't stand for it," Mayor Brandon Scott said, calling the nicotine pouches highly addictive. The city further accused the companies of falsely representing Zyn as tobacco-free and failing to warn customers about the increase in nicotine absorption compared to cigarettes. In the lawsuit, the city alleges that the company's reward program entices and retains young customers by offering discounts, free products and access to exclusive events. What are Zyn nicotine pouches? According to the lawsuit, Zyn pouches are meant to be placed between a person's lip and gums to deliver nicotine to the bloodstream. The pouches are made of stabilizers, fillers, pH adjusters, flavoring, sweetener and nicotine salt. Twenty flavors of the nicotine pouches were approved for sale by the Food and Drug Administration (FDA) in January. It was the first time that regulators authorized the sale of nicotine pouches, according to CBS News. The pouches were available for years before the FDA approved their use as an alternative to cigarettes. According to Zyn's warning label, the product is not intended for minors, women who are pregnant or breastfeeding or people with heart disease risk factors or high blood pressure. The lawsuit compares nicotine to cocaine and heroin for its addictive nature, and quotes Senator Chuck Schumer in calling the Zyn product a "pouch packed with problems." Zyn nicotine pouches gain popularity among young people In January, CBS News reported that Zyn pouches were becoming more popular among the younger generation. "We are hooking a whole new generation of young people onto nicotine," Dr. Nidhi Kumar said. "The marketing strategies, the packaging looks like candy, flavors like cinnamon and mint and even names like 'smooth' or 'chill.' I mean, who are these products appealing to? Young people." Another doctor told CBS News Miami that Zyn pouches seem to be more popular among boys. Dr. Marcos Mestre also warned parents to watch for signs of nicotine pouch use, which can include symptoms like sweating, nausea, palpitations and even mental health issues. "These can lead to mental health issues, including anxiety and depression," he said. "Any addictive behavior has the potential to lead to other problems." While some have argued that the pouches could help smokers cut back, others have raised health concerns. Some experts highlighted risks of cardiovascular and oral health impacts, saying the toxic chemicals could damage gums or lead to infection or cancer. "If you're using these products, just Google nicotine pouches and dental disease — you'll spit it out right away," Dr. Kumar said. If you or a loved one is experiencing a problem with substance use, help is available via the Substance Abuse and Mental Health Services Administration Helpline at 1-800-662-HELP.
Globe and Mail
16-04-2025
- Business
- Globe and Mail
Philip Morris International to Host Webcast of 2025 First-Quarter Results
Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Wednesday, April 23, 2025, at 9:00 a.m. ET, to discuss its 2025 first-quarter financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast will be hosted by Emmanuel Babeau, Chief Financial Officer, and will include discussion of PMI's financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at The webcast recording and the slides and script will be available at The recording will be available until 5:00 p.m. ET on Friday, May 23, 2025. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies' IQOS and ZYN brands. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates that 38.6 million adults around the world use PMI's smoke-free products. The smoke-free business accounted for approximately 39% of PMI's total full-year 2024 net revenues. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to 'PMI', 'we', 'our' and 'us' mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and
Yahoo
16-04-2025
- Business
- Yahoo
Philip Morris International to Host Webcast of 2025 First-Quarter Results
STAMFORD, CT, April 16, 2025--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Wednesday, April 23, 2025, at 9:00 a.m. ET, to discuss its 2025 first-quarter financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast will be hosted by Emmanuel Babeau, Chief Financial Officer, and will include discussion of PMI's financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at The webcast recording and the slides and script will be available at The recording will be available until 5:00 p.m. ET on Friday, May 23, 2025. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies' IQOS and ZYN brands. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates that 38.6 million adults around the world use PMI's smoke-free products. The smoke-free business accounted for approximately 39% of PMI's total full-year 2024 net revenues. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and View source version on Contacts Philip Morris International Investor Relations:Stamford, CT: +1 (203) 904 2410Lausanne: +41 (0)58 242 4666Email: InvestorRelations@ Media: David FraserLausanne: +41 (0)58 242 4500Email: Sign in to access your portfolio
The National
14-04-2025
- Health
- The National
Can UAE's smokers learn from 'clean tobacco' loving Sweden?
Sweden may have found the best alternative to traditional cigarettes - other than simply quitting. The rise in popularity of 'snus' tobacco pouches placed in the mouth are credited for falling cigarette use and lower deaths. Now, with a new UAE government regulation allowing oral nicotine pouches to be sold for the first time, the Emirates has a fresh weapon in the war on smoking. Can the Emirates, and heavy smoking nations in the Middle East, learn from Sweden's shift? Smoking rates in Sweden are a fraction of their EU counterparts, thanks in part to the use of snus among citizens. In 2018, lung cancer incidence was around 40 cases per 100,000 people in Sweden, compared with the EU average rate of 71 per 100,000 people. Sweden has a long relationship with snus, a tobacco product taken orally and placed between lip and gum for a slow nicotine release. For a decade or so, snus has been modernised and re-developed as a pure nicotine pouch. It has helped people, and women in particular, to quit cigarettes. Nicotine pouches are the electric car to the combustion engine age of tobacco smoking, and have been the driving force behind Sweden's record low cigarette use - and cancer rates. Around 12 per cent of the UAE population smokes, and around 20 per cent in the wider Middle East. Meanwhile, Sweden is well on course to become Europe's first smoke-free nation - defined by the World Health Organisation as a country with an adult smoking rate lower than 5 per cent. 'We have noticed that in Sweden we have less degree of smoke-related diseases compared to other countries and it's because we have fewer people who smoke compared to other countries,' said Dr Josef El-Achkar, a specialist in internal medicine and cardiology in Stockholm, Sweden. 'But the nicotine usage is not a big difference, it's how they take the nicotine. The inhalation and cigarette smoking seems to be the reason for why people get diseases, not the nicotine itself. There's also fewer cases of chronic obstructive pulmonary disease as a result of less smoking.' In 2018, lung cancer incidence was around 40 cases per 100,000 people in Sweden, compared with 113 in Hungary and an EU average rate of 71 per 100,000 people. With few nations regulating nicotine pouches to allow them on sale beyond duty-free airports, millions of smokers have been deprived of a less harmful alternative to cigarettes. Zyn - nicotine pouches developed and produced by Swedish Match - are available outside duty-free stores in only a few countries, including the US, UK, Switzerland, Hungary, South Africa, Finland, Poland, Serbia and Pakistan. In 2022, Philip Morris International, makers of Marlboro cigarettes, pushed through a $16 billion takeover of Swedish Match, to expand the company's global smoke-free agenda. The burning of tobacco creates the cancer-causing properties of conventional cigarettes. While nicotine is not entirely risk-free, smokeless products that perform in a similar way to nicotine patches will soon become more widely available. Some pouch users have experienced changes to gum infrastructure and oral health after long-term use, and nicotine itself is highly addictive. Sweden has slashed smoking rates and transitioned towards harm-reduction public health policy on tobacco. However, the country is one of the few nations with more female smokers (6.8 per cent), than males (5.9 per cent) - largely due to the popularity of snus with men. In 20th century industrial workplaces, snus was a familiar stimulant taken by male workers. Rolled up, clay-like balls of tobacco were tucked under the gum, allowing manual workers to free up their hands for labour, while continuing to take their daily nicotine habit. Patrik Strömer, secretary general of the Swedish Snus Manufacturers Association - an organisation that unites producers of snus and nicotine pouches, estimates there are some 1.2 million users in Sweden's population of almost 11 million. 'I think everybody has some kind of relation to snus,' he said. 'When the nicotine pouch entered the market 10 years ago, it was seen with both curiosity and scepticism. In the old-school tobacco users, they wanted to have the real stuff, but at the same time something that was seen as more fresh and contained no brown, wet tobacco.' The industry began to self-regulate products as they came on to the market. That included age limits, health warnings, restricted marketing and industry standards around the use of different kinds of substances. When Sweden's tobacco law came into force in July 2019, a smoking ban was enforced on outdoor restaurants and railway stations, further boosting the popularity of smokeless alternatives, particularly among women. 'Prior to that it was not seen as OK if a woman used nicotine pouches, so many smoked instead - it was a cultural thing,' Mr Strömer told The National. 'The traditional product was a cheap enjoyment for hardworking people. But you have to mould the tobacco and it is not very aesthetic or attractive, and it stains your fingers, so it was not very popular with woman at all. 'When Sweden joined the European Union, it was the only country where women smoked more than men. When you try to explain this rapid reduction in smoking prevalence among Swedish men, the answer is obvious. "When this new pouch entered the market, suddenly something became much more convenient, practical and discreet. From a sociological point of view, we have seen the effects. Now we have two smoke-free generations in Sweden, people aged 15 to 29 and 30 to 44.' Switching towards less harmful nicotine products has cut the number of Swedish-born adult smokers to 4.5 per cent - below the WHO-defined 5 per cent smoke-free threshold. That has contributed to 41 per cent fewer cancers cases than the European average, and 44 per cent fewer tobacco-related deaths. Despite those figures, introducing nicotine pouches in other nations with high smoking levels may not be a global panacea. In 2020, 22.3 per cent of the world's population used tobacco: 36.7 per cent of men and 7.8 per cent of women, and few nations have the same historic links to snus as Sweden, making the transition towards pouches a considerable challenge. Since December 2024, Sweden has enshrined tobacco harm reduction in public health policy, placing it at the vanguard of smoke-free ambition, and introduced a cap on nicotine levels in smokeless products. Limiting the strength of products helps regulate the market, experts say. Samuel Lundell, chairman of the National Association of Snus Users, said Sweden's history of smokeless tobacco has helped increase the wider adoption of nicotine pouches in the country. 'We have been using the products for hundreds of years, so we know a lot about what harm they do and the supporting research,' he said. 'Government agencies inform, but they don't always come from a harm-reduction perspective. 'That's where we have to really emphasise the huge difference you have in the health effects compared with cigarettes. On one hand you have a deadly product and then you have one which isn't deadly, so it should be an easy choice.' Social media links to the potential biohacking properties of nicotine, to improve attention or stimulation, are not scientifically proven but have fuelled a rise in use among young people, particularly in the US. That has reinforced calls for strong enforcement against underage sales. In Sweden, under-18s cannot legally buy snus or nicotine pouches. Potential links with cancer have also been scientifically debunked. A study of 400,000 male snus users by the Karolinska Institute in Stockholm found no association with a greater risk for pancreatic cancer, adding to claims oral nicotine is safer than smoking. 'The more time passes, the more of the old misconceptions we can throw away,' said Mr Lundell. 'I think it's possible to have a similar impact in the Middle East, at least if not in the absolute short term, but in a few years, absolutely. 'For young people, it's about accessing the information already out there. We already have the research, but we need to to get it across to people and that can become a bit tricky. 'A ban might be one of the worst public health decisions that could ever happen in a Middle Eastern country. Once a product has been banned, it's extremely hard to remove it. 'Meanwhile, we see millions of Europeans have lost their lives, it would be awful to see the same mistake elsewhere when there is an alternative.' * A visit to Sweden was facilitated by Philip Morris International
